HealthEquity (NASDAQ:HQY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
HealthEquity (NASDAQ:HQY) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $125.00 price target on the stock.
HealthEquity (NASDAQ:HQY) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets.
HealthEquity (NASDAQ:HQY) had its price target raised by analysts at JPMorgan Chase & Co. from $126.00 to $129.00. They now have an "overweight" rating on the stock.
HealthEquity (NASDAQ:HQY) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $130.00 price target on the stock.